Madan RA - Search Results

1

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.

Parsons JK, Pinto PA, Pavlovich CP, Uchio E, Nguyen MN, Kim HL, Gulley JL, Sater HA, Jamieson C, Hsu CH, Wojtowicz M, House M, Schlom J, Donahue RN, Dahut WL, Madan RA, Bailey S, Centuori S, Bauman JE, Parnes HL, Chow HS. Parsons JK, et al. Among authors: madan ra. Eur Urol Focus. 2023 May;9(3):447-454. doi: 10.1016/j.euf.2022.12.002. Epub 2022 Dec 12. Eur Urol Focus. 2023. PMID: 36517408 Free PMC article. Clinical Trial.

2

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits.

Madan RA, Karzai F, VanderWeele DJ, Cheng HH, de Bono JS. Madan RA, et al. J Clin Oncol. 2023 Dec 20;41(36):5501-5504. doi: 10.1200/JCO.23.01502. Epub 2023 Oct 17. J Clin Oncol. 2023. PMID: 37847874 Free PMC article.

3

PSA-based vaccines for the treatment of prostate cancer.

Madan RA, Gulley JL, Arlen PM. Madan RA, et al. Expert Rev Vaccines. 2006 Apr;5(2):199-209. doi: 10.1586/14760584.5.2.199. Expert Rev Vaccines. 2006. PMID: 16608420 Free article. Review.

4

PANVAC-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma.

Madan RA, Arlen PM, Gulley JL. Madan RA, et al. Expert Opin Biol Ther. 2007 Apr;7(4):543-54. doi: 10.1517/14712598.7.4.543. Expert Opin Biol Ther. 2007. PMID: 17373905 Review.

5

Significant prostate-specific antigen (PSA) response to low-dose ketoconazole in a patient with non-metastatic androgen-independent prostate cancer (AIPC) and a review of the literature.

Madan RA, Lieberman R, Gulley JL, Dahut W, Arlen PM. Madan RA, et al. Am J Ther. 2007 May-Jun;14(3):310-3. doi: 10.1097/01.pap.0000249955.77460.f4. Am J Ther. 2007. PMID: 17515709

6

Enhancing efficacy of therapeutic vaccinations by combination with other modalities.

Gulley JL, Madan RA, Arlen PM. Gulley JL, et al. Among authors: madan ra. Vaccine. 2007 Sep 27;25 Suppl 2(Suppl 2):B89-96. doi: 10.1016/j.vaccine.2007.04.091. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17573164 Free PMC article. Review.

7

Combining Vaccines with Conventional Therapies for Cancer.

Arlen PM, Madan RA, Hodge JW, Schlom J, Gulley JL. Arlen PM, et al. Among authors: madan ra. Update Cancer Ther. 2007 Mar;2(1):33-39. doi: 10.1016/j.uct.2007.04.004. Update Cancer Ther. 2007. PMID: 17948067 Free PMC article.

8

Preclinical and clinical studies of recombinant poxvirus vaccines for carcinoma therapy.

Arlen PM, Gulley JL, Madan RA, Hodge JW, Schlom J. Arlen PM, et al. Among authors: madan ra. Crit Rev Immunol. 2007;27(5):451-62. doi: 10.1615/critrevimmunol.v27.i5.40. Crit Rev Immunol. 2007. PMID: 18197807 Review.

9

Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy.

Madan RA, Gulley JL, Schlom J, Steinberg SM, Liewehr DJ, Dahut WL, Arlen PM. Madan RA, et al. Clin Cancer Res. 2008 Jul 15;14(14):4526-31. doi: 10.1158/1078-0432.CCR-07-5048. Clin Cancer Res. 2008. PMID: 18628467 Free PMC article. Clinical Trial.

10

Therapeutic prostate cancer vaccines: a review of the latest developments.

Mohebtash M, Madan RA, Gulley JL, Arlen PM. Mohebtash M, et al. Among authors: madan ra. Curr Opin Investig Drugs. 2008 Dec;9(12):1296-301. Curr Opin Investig Drugs. 2008. PMID: 19037836 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters